Previous Article | Next Article ![]()
J Virol, June 1998, p. 4694-4703, Vol. 72, No. 6
Division of Human Retrovirology,
Received 11 December 1997/Accepted 3 March 1998
Human immunodeficiency virus type 1 (HIV-1) entry into target cells
involves sequential binding of the gp120 exterior envelope glycoprotein
to CD4 and to specific chemokine receptors. Soluble CD4 (sCD4) is
thought to mimic membrane-anchored CD4, and its binding alters the
conformation of the HIV-1 envelope glycoproteins. Two cross-competing
monoclonal antibodies, 17b and CG10, that recognize CD4-inducible gp120
epitopes and that block gp120-chemokine receptor binding were used to
investigate the nature and functional significance of gp120
conformational changes initiated by CD4 binding. Envelope glycoproteins
derived from both T-cell line-adapted and primary HIV-1 isolates
exhibited increased binding of the 17b antibody in the presence of
sCD4. CD4-induced exposure of the 17b epitope on the oligomeric
envelope glycoprotein complex occurred over a wide range of
temperatures and involved movement of the gp120 V1/V2 variable loops.
Amino acid changes that reduced the efficiency of 17b epitope exposure
following CD4 binding invariably compromised the ability of the HIV-1
envelope glycoproteins to form syncytia or to support virus entry.
Comparison of the CD4 dependence and neutralization efficiencies of the
17b and CG10 antibodies suggested that the epitopes for these
antibodies are minimally accessible following attachment of gp120 to
cell surface CD4. These results underscore the functional importance of
these CD4-induced changes in gp120 conformation and illustrate viral strategies for sequestering chemokine receptor-binding regions from the
humoral immune response.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
CD4-Induced Conformational Changes in the Human
Immunodeficiency Virus Type 1 gp120 Glycoprotein: Consequences for
Virus Entry and Neutralization
*
Corresponding author. Mailing address: Dana-Farber
Cancer Institute, JFB824, 44 Binney St., Boston, MA 02115. Phone: (617) 632-3371. Fax: (617) 632-4338. E-mail:
Joseph_Sodroski{at}dfci.harvard.edu.
J Virol, June 1998, p. 4694-4703, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|